Please login to the form below

Not currently logged in
Email:
Password:

AAA

This page shows the latest AAA news and features for those working in and with pharma, biotech and healthcare.

Seattle Genetics moves to dismiss ADC lawsuit with Daiichi Sankyo

Seattle Genetics moves to dismiss ADC lawsuit with Daiichi Sankyo

Shortly after Daiichi Sankyo filed its lawsuit, Seattle Genetics submitted an arbitration demand to the American Arbitration Association (AAA), saying it had been abiding by the agreement’s dispute resolution provisions.

Latest news

  • AAA board presses go on $3.9bn Novartis takeover AAA board presses go on $3.9bn Novartis takeover

    Novartis offer to buy the company was made in October and – after negotiations with company’s works council – AAA’s board has now given its blessing to the $41 per share ... AAA was spun out 15 years ago from Cern, the European nuclear research

  • Novartis to buy French radiopharma specialist AAA for $3.9bn Novartis to buy French radiopharma specialist AAA for $3.9bn

    Among AAA’s clinical candidates is 177Lu-NeoBOMB1, a radiopharmaceutical for prostate cancer, gastrointestinal stromal tumours (GIST) and breast cancer. ... Novartis is offering $41 in cash per AAA ordinary share and $82 per American Depositary Share,

  • AAA’s orphan drug Lutathera wins EU green light AAA’s orphan drug Lutathera wins EU green light

    The first-in-class drug treats adults with GEP-NET. Advanced Accelerator Applications’ (AAA) Lutathera (lutetium oxodotreotide) has received European approval to treat adults with unresectable or metastatic, somatostatin receptor positive

  • IPA 2013 Best of Health Awards open for entries IPA 2013 Best of Health Awards open for entries

    ÂÂÂ Last year McCann Torre Lazur was awarded Healthcare Professional 'Best of Show' for its 'Another busy day' campaign, on behalf of the hypertension drug Edarbi by Takeda.

  • Market turmoil continues

    The biggest companies in the US have been downgraded from AAA rating to AA along with the dollar and the US Government.

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest from PMHub

  • Pegasus Pegasus

    AAA. Astellas. Bayer. Biogen. CSL Behring. GlaxoSmithKline. MSD Global. MSD UK.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics